| Auro Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530233 |
NSE Symbol : - |
P/E(TTM) : 156.54 |
|
ISIN Demat : INE292C01011 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.69 |
|
Book Value(₹) : 69.92 |
Market Cap(₹Cr) : 164.88 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 9.39 | 8.84 | 2.77 | 7.40 | 3.05 | 3.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 9.39 | 8.84 | 2.77 | 7.40 | 3.05 | 3.10 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.18 | 0.98 | 0.42 | 0.13 | 0.14 | 0.31 |
| Total Income | 9.57 | 9.81 | 3.19 | 7.53 | 3.20 | 3.41 |
| Total Expenditure | 5.33 | 6.48 | 2.74 | 6.59 | 2.61 | 2.38 |
| PBIDT | 4.24 | 3.33 | 0.45 | 0.94 | 0.58 | 1.03 |
| Interest | 1.52 | 0.96 | 0.28 | 0.30 | 0.25 | 0.28 |
| PBDT | 2.72 | 2.37 | 0.17 | 0.64 | 0.34 | 0.75 |
| Depreciation | 0.98 | 0.65 | 0.27 | 0.29 | 0.27 | 0.27 |
| Tax | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.12 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.21 | 1.00 | 0.00 | -0.06 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.95 | 0.72 | -0.11 | 0.39 | 0.05 | 0.36 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.95 | 0.72 | -0.11 | 0.39 | 0.05 | 0.36 |
| EPS (Unit Curr.) | 3.13 | 1.15 | -0.17 | 0.63 | 0.08 | 0.57 |
| EPS (Adj) (Unit Curr.) | 3.13 | 1.15 | -0.17 | 0.63 | 0.08 | 0.57 |
| Calculated EPS (Unit Curr.) | 3.13 | 1.15 | -0.17 | 0.63 | 0.08 | 0.57 |
| Calculated EPS (Adj) (Unit Curr.) | 3.13 | 1.15 | -0.17 | 0.63 | 0.08 | 0.57 |
| Calculated EPS (Ann.) (Unit Curr.) | 12.53 | 4.59 | -0.68 | 2.53 | 0.33 | 2.30 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 12.53 | 4.59 | -0.68 | 2.53 | 0.33 | 2.30 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 45.15 | 37.67 | 16.25 | 12.70 | 19.02 | 33.23 |
| PBDTM(%) | 28.97 | 26.81 | 6.14 | 8.65 | 11.15 | 24.19 |
| PATM(%) | 20.77 | 8.14 | -3.97 | 5.27 | 1.64 | 11.61 |